BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
ZSTK
ZeroStack Corp.
There isn't enough reported data to score ZSTK yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ZSTK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
ZSTK's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZSTK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ZSTK PE Valuation
ZSTK has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
ZSTK Forward outlook
There aren't enough analyst estimates for ZSTK to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus ZSTK down 165%.
ZSTK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$390.51 | +$207.12 |
| Q2 2023 | -$471.89 | +$114.27 |
| Q1 2023 | -$466.10 | -$75.87 |
| Q4 2022 | -$528.95 | -$173.32 |
ZSTK is still losing money, but less than at its worst: $390.51 per share over the past year, against $597.63 at its worst in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ZSTK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ZSTK on profitability, with a higher operating margin.
ZSTK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.7M | -7.7% |
| Q1 2026 | $7.3M | -38% |
| Q4 2025 | $9.4M | -30% |
| Q3 2025 | $9.7M | -22% |
| Q2 2025 | $14.8M | -5.7% |
| Q1 2025 | $11.8M | -35% |
| Q4 2024 | $13.3M | -26% |
| Q3 2024 | $12.5M | -28% |
ZSTK's revenue has slid since its 2023 peak: $14M last quarter, down 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -177% | -160 points |
| Q1 2026 | -861% | -853 points |
| Q4 2025 | -1596% | -1551 points |
| Q3 2025 | -34% | -3.9 points |
| Q2 2025 | -17% | +5.2 points |
| Q1 2025 | -8.3% | +5.5 points |
| Q4 2024 | -45% | -3.4 points |
| Q3 2024 | -30% | -27 points |
ZSTK's operating margin was −177% last quarter, down 160 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over ZSTK on cash generation, producing positive trailing cash flow while its opponent burns cash.
ZSTK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.4M | +$4.3M |
| Q1 2026 | -$3.8M | -$1.1M |
| Q4 2025 | -$3.2M | -$1.8M |
| Q3 2025 | $91K | +$2.2M |
| Q2 2025 | -$3M | -$2.7M |
| Q1 2025 | -$2.8M | -$1.3M |
| Q4 2024 | -$1.3M | -$253K |
| Q3 2024 | -$2.1M | -510% |
ZSTK's free cash flow was −$6M over the past year, against −$9M the year before. Free cash flow isn't a meaningful measure for financial services companies like ZSTK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ZSTK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ZSTK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +64% | +69.4K shares |
| 1 year | +99% | +88.8K shares |
ZSTK has 178,000 diluted shares, up 99% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $5,000 |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ZSTK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -0.9x | Net Cash |
ZSTK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ZSTK.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ZSTK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 11.0 | Oversold |
ZSTK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ZSTK PE vs Financial Services Sector
ZSTK has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over ZSTK on trend strength, trading above more of its moving averages.
ZSTK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.58 | 30% below |
| 20 week MA | $3.32 | 24% below |
| 50 week MA | $5.44 | 54% below |
| 100 week MA | $14.8 | 83% below |
| 200 week MA | $53.8 | 95% below |
ZSTK is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ZSTK on returns for 2026, with the stronger performance.
ZSTK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3,159.0 | $1,560.0 | -51% |
| 2022 | $1,560.0 | $189.5 | -88% |
| 2023 | $189.5 | $52.7 | -72% |
| 2024 | $52.7 | $39.8 | -24% |
| 2025 | $39.8 | $7.28 | -82% |
| 2026 YTD | $7.28 | $2.51 | -66% |
ZSTK has finished every year since 2021 lower, and it's down 66% so far in 2026.